Nintedanib is an anti-fibrotic medication used to treat idiopathic pulmonary fibrosis (IPF). It works by inhibiting growth factor receptors involved in fibrosis, thereby slowing disease progression. Nintedanib is effective in improving lung function and quality of life for patients with IPF. Common side effects may include diarrhea, nausea, and liver enzyme elevations. In summary, Nintedanib is crucial for managing IPF.
Nintedanib inhibits multiple receptor tyrosine kinases, reducing fibroblast proliferation and collagen deposition in lung tissue.





